StocksInsight

CNA Stock vs the S&P 500: Returns, Risk and Crash History

CNA Financial Corporation, financial services (market value $13.1 billion): how it compared with the S&P 500, how it behaved in every crash since 2008, its risk‑adjusted returns and what analysts said. Returns to Oct 30, 2026; analyst data as of Nov 16, 2026.

Published Updated 4 min readHow we research

What changed since Nov 9

Exent re-checks this page every day. Ratings appear 30 days after they are published; the top‑ranked analysts’ calls are not counted here, they are in Gems.

+1 new rating

Key takeaways

  • CNA returned +60.0% over the 5 years to Oct 30, 2026 versus +75.9% for the S&P 500: it lagged the index.
  • Its 5-year Sharpe ratio was 0.39 against 0.58 for the S&P 500.
  • Its deepest crisis drawdown was −84.2% in the global financial crisis (2007–09) (S&P 500: −56.5%).
  • Five‑year volatility was 21.5% and beta 0.22.
  • 1 analysts rated it in the past year; 0% of their latest calls were Buy.
  • CNA beat earnings estimates in 7 of its last 12 reports; the stock moved 2.4% on average, up or down, around each report.

What do the best‑ranked analysts on CNA say now? See it in Exent Gems →

Did CNA beat the S&P 500?

Over the 5 years to Oct 30, 2026, CNA Financial Corporation (CNA) returned +60.0% including dividends, versus +75.9% for the S&P 500 (SPY). It lagged the index by 15.9 percentage points, or +9.9% a year against +12.0%.

PeriodCNAS&P 500CNA per yearS&P 500 per yearResult
1 year+18.5%+12.0%+18.5%+12.0%Beat
3 years+53.7%+87.4%+15.4%+23.3%Lagged
5 years+60.0%+75.9%+9.9%+12.0%Lagged
10 years+176.9%+316.3%+10.7%+15.3%Lagged
  • 1 year
    CNA
    +18.5%
    S&P 500
    +12.0%
    CNA per year
    +18.5%
    S&P 500 per year
    +12.0%
    Result
    Beat
  • 3 years
    CNA
    +53.7%
    S&P 500
    +87.4%
    CNA per year
    +15.4%
    S&P 500 per year
    +23.3%
    Result
    Lagged
  • 5 years
    CNA
    +60.0%
    S&P 500
    +75.9%
    CNA per year
    +9.9%
    S&P 500 per year
    +12.0%
    Result
    Lagged
  • 10 years
    CNA
    +176.9%
    S&P 500
    +316.3%
    CNA per year
    +10.7%
    S&P 500 per year
    +15.3%
    Result
    Lagged

Total return with dividends reinvested, from month-end prices to Oct 30, 2026. Beating the index on raw return is only half the story: the next section adjusts for the risk taken. See also how to beat the S&P 500.

What Wall Street analysts say about CNA

In the 12 months to 30 days ago, 1 analysts published 11 ratings on CNA. Their latest calls were 0% Buy, 0% Hold and 100% Sell. 1 of them rank 4★ or higher in Exent’s analyst scoring, which is based on each analyst’s past price‑target hit rate and returns.

The consensus 12‑month price target was $45.00 (range $45.00–$45.00), −7.2% from the last price. Remember that the average analyst’s target is hit only about half the time: how accurate are price targets?

Top‑ranked analyst coveringFirmStarsPrice‑target hit rate
Joshua ShankerBank of America Securities4.7★48.4%

Ratings are shown with a 30‑day delay. Who the top‑ranked analysts on CNA are, their live calls and the median target of only the top‑rated analysts are in Exent Gems.

The average analyst’s target is reached about 53.0% of the time; Exent Gems is built on the top 50 of Exent’s ranking,where some reached 90% or more over the last two years. Unlock the top 50 analysts.

CNA returns by year vs the S&P 500

CNA beat the S&P 500 in 2 of the 9 full calendar years shown.

YearCNAS&P 500Difference
2026 (to Oct 30, 2026)+9.5%+11.7%−2.2%
2025+7.0%+17.7%−10.7%
2024+24.0%+24.9%−0.9%
2023+7.1%+26.2%−19.1%
2022+3.8%−18.2%+22.0%
2021+19.1%+28.7%−9.6%
2020−5.4%+18.3%−23.7%
2019+9.5%+31.2%−21.7%
2018−11.1%−4.6%−6.5%
2017+36.9%+21.7%+15.2%

CNA risk-adjusted returns: Sharpe, Sortino and volatility

Over 5 years, CNA had a Sharpe ratio of 0.39 against 0.58 for the S&P 500, so it earned less return per unit of risk than the index. Its annualized volatility was 20.1% and its beta 0.22: it tended to move about 0.2× as much as the market.

MetricCNAS&P 500
Annual return+9.9%+12.0%
Volatility (annualized)20.1%15.5%
Sharpe ratio0.390.58
Sortino ratio0.610.91
Max drawdown (month-end)−22.7%−23.9%
Beta to the S&P 5000.221.00

Sharpe divides return above cash by total volatility; Sortino counts only downside volatility. Both use monthly returns and the 1–3 month T‑bill ETF (BIL) as the risk‑free rate.

How CNA behaved in past crashes

CNA’s deepest fall in the crises below was −84.2% in the global financial crisis (2007–09), against −56.5% for the S&P 500. The last column turns that into money: what a $100,000 position would have lost from peak to trough.

CrisisCNAS&P 500Loss on $100,000
Global financial crisis (2007–09)−84.2%−56.5%−$84,150
2018 trade-war selloff−12.9%−20.2%−$12,910
COVID crash (Feb–Mar 2020)−46.0%−34.1%−$46,000
2022 inflation bear market−27.1%−25.4%−$27,060
2025 tariff selloff−11.6%−19.0%−$11,570
WindowCNA max drawdown
Last 1 year−18.1%
Last 3 years−18.1%
Last 5 years−25.7%
Last 10 years−52.8%

Peak‑to‑trough declines from daily prices inside each crisis window. A crash replay does not predict the next crisis; it shows how much room a holding needs. Run the same replay on a whole portfolio with the crash test.

What moves with CNA, and what doesn’t

Correlation runs from −1 (moves opposite) to +1 (moves in lockstep). Over the last 60 months of monthly returns, CNA’s correlation with the S&P 500 was 0.17, with the Nasdaq‑100 −0.09, with long Treasuries (TLT) 0.12 and with gold (GLD) −0.05.

Adding a 5% CNA position to an S&P 500 portfolio would have moved its 5‑year volatility from 15.5% to 14.9%.

Least correlated large capsCorrelationMost correlated large capsCorrelation
ORCL−0.29BRK-B0.63
AMD−0.26PGR0.59
NOW−0.25MRSH0.58
DELL−0.25MO0.53
SNOW−0.25V0.53

Holdings that are highly correlated behave like one position in a selloff. See how to find hidden overlap.

Latest CNA upgrades, downgrades and price‑target changes

DateRating and targetAnalyst
Nov 2Target raised
Sell
Target $48, was $45
Joshua Shanker
Bank of America Securities
Oct 12Target cut
Sell
Target $45, was $49
Joshua Shanker
Bank of America Securities

Named analysts’ rating and price‑target changes on CNA in the 5 weeks to Oct 20, 2026, shown 30 days after publication (the free analysts’ calls 3 days after). The top‑ranked analysts’ calls are in Exent Gems. See all of the latest analyst upgrades and downgrades.

Do analysts get CNA right?

Of the 31 analyst price targets on CNA set from 2019 until a year ago, 58.1% were reached within 12 months (data to Oct 20, 2026), 10.5 points below the 68.6% hit rate of the median stock in Exent’s study of 794 stocks. Targets that were reached took a median of 68 days. The median target sat 4.8% above the share price on the day it was set.

58.1%of targets reached within 12 monthsMedian stock: 68.6%
68 daysmedian time to reach a target
AfterCallsMove on the call3 months vs S&P 500
Upgrades of CNA3+0.9%+2.3%
Upgrades, all stocks11,514+2.5%+3.4%
Downgrades of CNA3−0.8%+2.0%
Downgrades, all stocks10,700−3.0%−1.6%

The move on the call runs from the close before the rating change to the close after it; the last column is the stock’s return minus the S&P 500’s over the next three months. Averages of rating changes on CNA through Sep 15, 2026; analysts are not named here. Do analyst upgrades move stocks?

How CNA moves after earnings

CNA beat the consensus earnings‑per‑share estimate in 7 of its last 12 quarterly reports, through the one on Aug 3, 2026, and the revenue estimate in 8 of 12. From the close before each report to the close after it, the stock moved 2.4% on average, up or down, against 6.8% for the average report across the 1,002 US stocks Exent tracks. It rose after 5 of the 12 reports. In 3 of the 7 beats the stock still fell.

7/12earnings beats
±2.4%average move per report
5/12reports followed by a rise
ReportEPS vs estimateRevenue vs estimateStock move
Aug 3, 2026$1.19 vs $1.04+28.7%+0.9%
May 4, 2026$0.83 vs $1.49−11.3%−7.3%
Feb 9, 2026$1.16 vs $1.20+30.4%−2.1%
Nov 3, 2025$1.50 vs $1.25+32.2%−0.5%
Aug 4, 2025$1.23 vs $0.94+34.7%+6.1%
May 5, 2025$1.03 vs $1.14+35.4%−0.2%
Feb 10, 2025$1.25 vs $1.11−2.5%−0.1%
Nov 4, 2024$1.08 vs $1.07+1.5%−0.1%

Reported earnings per share against the consensus estimate, revenue surprise in percent, and the stock’s price change over the two sessions around the report. How stocks move after earnings

Where CNA’s revenue comes from

In fiscal 2025 (the year to Dec 31, 2025), CNA’s largest reported region was Specialty, with 100.0% of its $5.7 billion revenue.

By business, the largest segment was Commercial Segment, with 43.3% of $15.0 billion revenue (+24.5% on the year before).

SegmentRevenueShareGrowth
Commercial Segment$6.5 billion43.3%+24.5%
Specialty Segment$5.7 billion38.0%+3.8%
International Segment$1.5 billion9.8%+14.7%
Life and Group Non-Core Segment$1.3 billion8.9%−0.7%

From CNA’s annual filings; segment growth compares fiscal 2025 with the year before. Regions are as each company reports them, so one company’s “Asia Pacific” is not another’s. China counts the regions a company reports as China, Greater China or Hong Kong; a separately reported Taiwan is not counted. Which S&P 500 companies depend most on China?

Are CNA insiders buying or selling?

In the 12 months to Oct 20, 2026, CNA insiders made no open‑market purchases and 12 sales worth $2.7 million, according to SEC Form 4 filings. The last open‑market purchase on record was on Mar 13, 2025.

After the 33 insider purchases of $10,000 or more since 2012, CNA beat the S&P 500 by an average of 8.0 percentage points over the next 12 months; 52% of them were followed by a beat. Across all 17,865 insider purchases in Exent’s study, the average was +17.2% and the median +1.0% against the index.

Q3 ’24
Q4 ’24
Q1 ’25
Q2 ’25
Q3 ’25
Q4 ’25
Q1 ’26
Q3 ’26
DateInsiderRoleValue
Mar 13, 2025Robusto DinoDirector, officer: Executive Chairman$34,701
Aug 2, 2023Loews Corp10 percent owner$175.1 million
May 3, 2023Loews Corp10 percent owner$190,992
May 2, 2023Loews Corp10 percent owner$1.4 million
May 1, 2023Loews Corp10 percent owner$1.4 million

The table lists the latest open‑market purchases on record, leaving out the last 30 days. The chart counts Form 4 purchases and sales by calendar quarter. Purchases are open‑market buys; sales include planned sales under 10b5‑1 trading plans. Do insider buys beat the market?

How much of CNA is sold short?

As of the Sep 30, 2026 settlement date, 1.42% of CNA’s float was sold short: 3.8 million shares, or 5.0 days of average trading volume to cover. A year earlier (Oct 15, 2025) it was 0.68%. The median across the 997 US stocks Exent tracks was 4.77%, so CNA is less heavily shorted than most.

  • Apr 30, 20260.86%
  • May 29, 20261.06%
  • Jun 30, 20261.15%
  • Jul 31, 20261.07%
  • Aug 31, 20261.41%
  • Sep 30, 20261.42%

From FINRA short‑interest reports, filed twice a month; the bars show the short share of the float at each month‑end. Days to cover divides the shares short by the average daily volume. The most shorted stocks

How many institutions own CNA?

At the end of Q2 2026 (Jun 30, 2026), 318 institutions reported holding CNA in 13F filings, up 22 from the quarter before and up from 268 a year earlier. Their reported holdings add up to 101.0% of CNA’s shares. In the quarter 167 institutions added to their positions and 104 cut them.

31813F holders
58new positions
40positions closed
101.0%of shares held by 13F filers

Investment managers with over $100 million in US equities file 13F reports within 45 days of each quarter end, so this is the latest complete quarter. Holdings can add up to more than 100% when shares are lent and counted twice. Which stocks institutions are buying and selling

Is CNA diluting shareholders?

CNA’s diluted share count fell 0.2% over the five fiscal years to fiscal 2025 and fell 0.1% in fiscal 2025 alone. Each share now owns a larger slice of the company. The median change across the 1,005 US stocks Exent tracks was −0.1%.

CNA spent $34.0 million buying back shares, a buyback yield of 0.26% of its market value; stock pay equaled 0.0% of the buybacks.

−0.1%share count, 1 year
−0.2%share count, 5 years
0.0%stock pay as % of revenue
0.26%buyback yield

Weighted‑average diluted shares from CNA’s annual income statements; stock‑based compensation and buybacks from its cash‑flow statement. Stock dilution and stock‑based compensation, explained

CNA financial health scores

In Exent’s Oct 20, 2026 snapshot, CNA’s Piotroski F‑score was 7 out of 9; 40% of scored stocks reach 7 or more. The Altman Z‑score is not meaningful for financial services companies, so it is left out.

The Altman Z‑score combines five balance‑sheet and earnings ratios into one bankruptcy‑risk score: below 1.81 is the distress zone, 1.81–2.99 grey, above 2.99 safe. It is not meaningful for banks, insurers and REITs. The Piotroski F‑score counts nine yes/no tests of profitability, leverage and efficiency; 8–9 is strong, 0–2 weak. Both come from the latest annual statements. Which stocks have the highest bankruptcy risk?

Which ETFs hold CNA?

As of Oct 20, 2026, 19 of the 304 ETFs Exent tracks held CNA. Its largest weight is in FNDA (Schwab Fundamental U.S. Small Company Index ETF), at 0.06% of the fund.

ETFFundWeight of CNA
FNDASchwab Fundamental U.S. Small Company Index ETF0.06%
SPEUSPDR Portfolio Europe ETF0.06%
SPDWSPDR Portfolio Developed World ex-US ETF0.04%
SCHDSchwab U.S. Dividend Equity ETF0.03%
SCHMSchwab U.S. Mid-Cap ETF0.02%
VXFVanguard Extended Market Index Fund ETF Shares0.01%
IWSiShares Russell Mid-Cap Value ETF0.01%
IWRiShares Russell Mid-Cap ETF0.01%

Owning several of these funds stacks the same position. How much do VOO, QQQ and VTI overlap?

The right benchmark for CNA

Exent matches every holding to the index with the most similar risk. For CNA that is MDY. Comparing a holding with an index that carries very different risk makes good results look bad and risky ones look clever. Read why the S&P 500 is the wrong benchmark for most portfolios.

Other financial services stocks

TickerName5‑year returnVolatility (5y)
BRK-BBerkshire Hathaway Inc.+89.0%17.3%
JPMJPMorgan Chase & Co.+124.6%24.4%
VVisa Inc.+102.8%22.7%
SEICSEI Investments Company+75.3%22.3%
KKRSKKR Group Finance Co. IX LLC 4.−21.8%16.3%
IVZInvesco Ltd.+34.9%36.4%
ARCCAres Capital Corporation+43.6%20.2%
GLGlobe Life Inc.+86.3%42.9%

Data and methodology

Returns are total returns from month‑end adjusted closing prices (dividends reinvested) through Oct 30, 2026. Crisis drawdowns and trailing maximum drawdowns use daily prices. Analyst coverage counts ratings published in the last 12 months, shown with a 30‑day delay. Full method: Exent methodology.

Company data as of Oct 20, 2026. The move around an earnings report runs from the close before it to the close after it; a price target counts as hit when the stock closed at or beyond it within 12 months (Exent analyst data). Revenue by region and segment, share counts and executive pay come from company filings; insider trades from SEC Form 4, short interest from FINRA, institutional ownership from 13F filings, Congress trades from STOCK Act disclosures filed with the House and Senate, federal contracts from USAspending.gov. Filings from the last 30 days are shown as counts only.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Check CNA with Exent Gems

Wall Street’s average CNA price target is 7.2% below the latest share price. See what the best‑ranked analysts on CNA say now in Exent Gems.

  1. Exent ranks Wall Street analysts by their past price‑target hit rate and returns, and keeps the best‑ranked few.
  2. Gems shows who the top‑ranked analysts covering CNA are, their live calls and the median target of only the top‑rated analysts.
  3. Gems flags the stocks where several top‑ranked analysts agree: a starting point for your own research, not a promise.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

No. CNA returned +176.9% (+10.7% a year) over the 10 years to Oct 30, 2026, versus +316.3% (+15.3% a year) for the S&P 500, including dividends.

No. As of Oct 20, 2026, CNA (CNA Financial Corporation) is not one of the 503 stocks in the S&P 500.

CNA fell −84.2% from peak to trough during the global financial crisis (2007–09), versus −56.5% for the S&P 500.

CNA fell −46.0% from peak to trough during the covid crash (feb–mar 2020), versus −34.1% for the S&P 500.

CNA fell −27.1% from peak to trough during the 2022 inflation bear market, versus −25.4% for the S&P 500.

Over the 5 years to Oct 30, 2026, CNA’s Sharpe ratio was 0.39 and its Sortino ratio 0.61, versus 0.58 and 0.91 for the S&P 500.

CNA’s 5‑year annualized volatility was 21.5%, higher than the S&P 500’s 17.0%, with a beta of 0.22.

Among large US stocks, the lowest correlations with CNA over the last 60 months were ORCL (−0.29), AMD (−0.26), NOW (−0.25). Its correlation with long Treasuries (TLT) was 0.12 and with gold (GLD) −0.05.

CNA beat the consensus earnings-per-share estimate in 7 of its last 12 quarterly reports through Aug 3, 2026, and the revenue estimate in 8 of 12. The stock moved 2.4% on average, up or down, from the close before each report to the close after it.

As of the Sep 30, 2026 settlement date, 1.42% of CNA’s float was sold short (3.8 million shares, 5.0 days to cover), according to FINRA short-interest reports. A year earlier it was 0.68%.

No. CNA’s diluted share count fell 0.2% over the five fiscal years to fiscal 2025 and fell 0.1% in the latest year. Stock-based compensation was 0.0% of revenue, and buybacks totaled $34.0 million.

What do the best‑ranked analysts say on CNA now?

Exent ranks Wall Street analysts by their track record. Gems shows who the top‑ranked analysts on CNA are, their latest calls and the stocks where several of them agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.